Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes

Eric Padron, Markus C. Ball, Jamie K. Teer, Jeffrey S. Painter, Sean J. Yoder, Chaomei Zhang, Ling Zhang, Lynn C. Moscinski, Dana E. Rollison, Steven D. Gore, Rafael Bejar, Matthew J. Walter, Mikkael A. Sekeres, Rami S. Komrokji, Pearlie K. Epling-Burnette

Blood (2018) 131 (21): 2402–2405.

https://doi.org/10.1182/blood-2018-01-827881

Published: 2018

Includes: Supplemental data

Journal Articles

Clonal Hematopoiesis Is Associated with Therapy-Related Myeloid Malignancies in the Elderly

Nancy K Gillis, PharmD, Markus Ball, PhD, Qing Zhang, MD, YuLong Zhao, PhD, Sean Yoder, M.S, Maria E. Balasis, Tania E. Mesa, David Sallman, MD, Jeffrey E. Lancet, MD, Rami S. Komrokji, MD, Alan F List, MD, Howard L McLeod, PharmD, Dana E Rollison, PhD, Eric Padron, MD

Blood (2016) 128 (22): 295.

https://doi.org/10.1182/blood.V128.22.295.295

Published: 2016

Journal Articles

Subsequent Primary Malignancies Among Multiple Myeloma Patients Treated with or without Lenalidomide

Dana E Rollison, PhD, Rami Komrokji, MD, Ji-Hyun Lee, PhD, Shalaka S Hampras, PhD, William Fulp, Kate Fisher, MA, Rachid Baz, MD, Taiga Nishihori, MD, Marta Olesnyckyj, Laurie Kenvin, BSN, RN, Robert D. Knight, MD, Daniel M Sullivan, MD, Melissa Alsina, MD, William Dalton, PhD MD, Kenneth H. Shain, MD PhD

Blood (2014) 124 (21): 2129.

https://doi.org/10.1182/blood.V124.21.2129.2129

Published: 2014

Journal Articles

Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients

Dana E Rollison, PhD, Kenneth H. Shain, MD PhD, Ji-Hyun Lee, PhD, Shalaka S Hampras, PhD, William Fulp, Kate Fisher, MA, Najla H Al Ali, Eric Padron, MD, Jeffrey Lancet, Qiang Xu, PhD, Robert D. Knight, MD, Alan F. List, MD, William Dalton, PhD MD, Rami Komrokji, MD

Blood (2014) 124 (21): 1912.

https://doi.org/10.1182/blood.V124.21.1912.1912

Published: 2014

Journal Articles

Subsequent Primary Malignancies Among Myelodysplastic Syndrome Patients Treated with or without Lenalidomide

Dana E Rollison, PhD, Kenneth H. Shain, MD PhD, Ji-Hyun Lee, PhD, Shalaka S Hampras, PhD, Kate Fisher, MA, Najla H Al Ali, Eric Padron, MD, Jeff E Lancet, MD, Marta Olesnyckyj, Laurie Kenvin, BSN, RN, Robert D. Knight, MD, William Dalton, PhD MD, Alan F. List, MD, Rami Komrokji, MD

Blood (2014) 124 (21): 413.

https://doi.org/10.1182/blood.V124.21.413.413

Published: 2014

Journal Articles

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

Blood (2012) 120 (21): 2823.

https://doi.org/10.1182/blood.V120.21.2823.2823

Published: 2012

Journal Articles

Human Telomerase Reverse Transcriptase (hTERT) Deficiency in Myelodysplastic Syndrome (MDS) Demonstrates Mechanistic Linkage to Aplastic Anemia Pathophysiology

Lili Yang, PhD, Adam W Mailloux, PhD, Dana E Rollison, PhD, Jong Park, PhD, Jeffrey S. Painter, B.S., Rami S. Komrokji, MD, Jaroslaw P Maciejewski, MD, PhD, Ronald Paquette, MD, PhD, Thomas P. Loughran, Jr., MD, Sheng Wei, MD, Alan F. List, MD, Pearlie K Epling-Burnette, Pharm D, PhD

Blood (2011) 118 (21): 791.

https://doi.org/10.1182/blood.V118.21.791.791

Published: 2011

Journal Articles

Tobacco Use Influences Disease Outcome and AML Potential in Myelodysplastic Syndromes,

Rami S. Komrokji, MD, Dana E Rollison, PhD, Najla H Al Ali, M.S, Maria Corrales-Yepez, MD, Pearlie K Epling-Burnette, PhD, Jeffrey E. Lancet, MD, Alan F. List, MD

Blood (2011) 118 (21): 3790.

https://doi.org/10.1182/blood.V118.21.3790.3790

Published: 2011

Journal Articles

Obesity Is Poor Prognostic Factor in Lower Risk Myelodysplastic Syndrome

Asmita Mishra, MD, Dana E Rollison, PhD, Najla H Al Ali, M.S, Maria Corrales-Yepez, MD, Pearlie K Epling-Burnette, PhD, Jeffrey E. Lancet, MD, Alan F. List, MD, Rami S. Komrokji, MD

Blood (2011) 118 (21): 5018.

https://doi.org/10.1182/blood.V118.21.5018.5018

Published: 2011

Journal Articles

Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries

Christopher R. Cogle, Benjamin M. Craig, Dana E. Rollison, Alan F. List

Blood (2011) 117 (26): 7121–7125.

https://doi.org/10.1182/blood-2011-02-337964

Published: 2011

Journal Articles

Predisposition to Myelodysplastic Syndrome with Deletion 5q Is Associated with TP53 Codon 72 Genotype

Blood (2010) 116 (21): 612.

https://doi.org/10.1182/blood.V116.21.612.612

Published: 2010

Journal Articles

Importance of T-Cell Proliferative Stress In Myelodysplastic Syndrome

Lili Yang, PhD, Amber Schmidt, Undergraduate, Rami Komrokji, MD, Jeffrey S. Painter, BS, Ashley Cole, Alan F. List, MD, Dana E. Rollison, PhD, P.K. Epling-Burnette, PharmD, PhD

Blood (2010) 116 (21): 2939.

https://doi.org/10.1182/blood.V116.21.2939.2939

Published: 2010

Journal Articles

Positive Impact of T-Cell Clonal Expansion On Overall Survival in Patients with High-Risk Myelodysplastic Syndromes.

Amber Schmidt, Rami S. Komrokji, MD, Jeffrey S. Painter, B.S., Dana E Rollison, PhD, Ling Zhang, MD, Lynn C. Moscinski, MD, Alan F List, MD, P.K. Epling-Burnette, PhD

Blood (2009) 114 (22): 1572.

https://doi.org/10.1182/blood.V114.22.1572.1572

Published: 2009

Journal Articles

Pathogenetic Role of Impaired Telomere Repair in Myelodysplastic Syndrome.

P.K. Epling-Burnette, PhD, Alan F List, MD, Justine Clark, MS, Ji-Hyun Lee, Kristen A. Jonathan, William Fulp, Xiaohong Li, Weipeng Zheng, Jeffrey S. Painter, B.S., JianXiang Zou, MD, Rami S. Komrokji, MD, Sheng Wei, MD, Jong Park, Amber Schmidt, Undergraduate, student, Chiharu Sugimori, MD, Ashley Cole, Dana E Rollison, PhD

Blood (2009) 114 (22): 2777.

https://doi.org/10.1182/blood.V114.22.2777.2777

Published: 2009

Journal Articles

A Keyword Search Strategy to Identify Missed Cases of Myelodysplastic Syndromes in Population-Based Cancer Registries.

Christopher R Cogle, MD, Ashley Cole, Iman Imanirad, M.D., Leena Kamat, Daohai Yu, Ph.D., Alan F List, MD, Dana E Rollison, PhD

Blood (2009) 114 (22): 4852.

https://doi.org/10.1182/blood.V114.22.4852.4852

Published: 2009

Journal Articles

Expression of Cellular Senesence Associated B-Galactosidase (SABG) Is up-Regulated in Melodysplastic Syndrome

Loveleen C. Kang, MD, Kathy Rocha, Dana E Rollison, PhD, Lynn C. Moscinski, MD, Alan F. List, MD

Blood (2008) 112 (11): 2684.

https://doi.org/10.1182/blood.V112.11.2684.2684

Published: 2008

Journal Articles

Short Telomere Length as a Risk Factor for Myelodysplastic Syndromes: A Case-Control Study

Dana E Rollison, PhD, Alan F. List, Ji-Hyun Lee, Kristen A. Jonathan, William Fulp, Xiaohong Li, Weipeng Zheng, Jeff Painter, Jong Park, PK Epling-Burnette

Blood (2008) 112 (11): 2674.

https://doi.org/10.1182/blood.V112.11.2674.2674

Published: 2008

Journal Articles

Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome

JianXiang Zou, MD, Dana E Rollison, PhD, David Boulware, MS, Elaine M. Sloand, MD, Loretta Pfannes, BS, Fanqi Bai, MD, Jeffrey S. Painter, BS, Sheng Wei, MD, Denise Cosgrove, RN, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2008) 112 (11): 3647.

https://doi.org/10.1182/blood.V112.11.3647.3647

Published: 2008

Journal Articles

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

Dana E. Rollison, Nadia Howlader, Martyn T. Smith, Sara S. Strom, William D. Merritt, Lynn A. Ries, Brenda K. Edwards, Alan F. List

Blood (2008) 112 (1): 45–52.

https://doi.org/10.1182/blood-2008-01-134858

Published: 2008

Journal Articles

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Pearlie K. Epling-Burnette, Fanqi Bai, Jeffrey S. Painter, Dana E. Rollison, Helmut R. Salih, Matthias Krusch, JianXiang Zou, Edna Ku, Bin Zhong, David Boulware, Lynn Moscinski, Sheng Wei, Julie Y. Djeu, Alan F. List

Blood (2007) 109 (11): 4816–4824.

https://doi.org/10.1182/blood-2006-07-035519

Published: 2007

Includes: Supplemental data

NARROW

Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes

Clonal Hematopoiesis Is Associated with Therapy-Related Myeloid Malignancies in the Elderly

Subsequent Primary Malignancies Among Multiple Myeloma Patients Treated with or without Lenalidomide

Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients

Subsequent Primary Malignancies Among Myelodysplastic Syndrome Patients Treated with or without Lenalidomide

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

Human Telomerase Reverse Transcriptase (hTERT) Deficiency in Myelodysplastic Syndrome (MDS) Demonstrates Mechanistic Linkage to Aplastic Anemia Pathophysiology

Tobacco Use Influences Disease Outcome and AML Potential in Myelodysplastic Syndromes,

Obesity Is Poor Prognostic Factor in Lower Risk Myelodysplastic Syndrome

Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries

Predisposition to Myelodysplastic Syndrome with Deletion 5q Is Associated with TP53 Codon 72 Genotype

Importance of T-Cell Proliferative Stress In Myelodysplastic Syndrome

Positive Impact of T-Cell Clonal Expansion On Overall Survival in Patients with High-Risk Myelodysplastic Syndromes.

Pathogenetic Role of Impaired Telomere Repair in Myelodysplastic Syndrome.

A Keyword Search Strategy to Identify Missed Cases of Myelodysplastic Syndromes in Population-Based Cancer Registries.

Expression of Cellular Senesence Associated B-Galactosidase (SABG) Is up-Regulated in Melodysplastic Syndrome

Short Telomere Length as a Risk Factor for Myelodysplastic Syndromes: A Case-Control Study

Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only